$97.53
-0.33-0.34%
At close: -
$97.53
0.000.00%
After Hours: Jan 17, 4:43 PM EDT
Comments
Loading...
Latest news for Novartis (NYSE:NVS) Stock
Novartis Stock (NYSE: NVS)
Categories: All
Thursday, January 16, 2025
Monday, January 13, 2025
Friday, January 10, 2025
Wednesday, January 08, 2025
Monday, January 06, 2025
Monday, December 30, 2024
Thursday, December 19, 2024
Wednesday, December 18, 2024
Friday, December 13, 2024
Monday, December 09, 2024
Friday, December 06, 2024
Tuesday, December 03, 2024
Monday, December 02, 2024
Wednesday, November 27, 2024
Thursday, November 21, 2024
Wednesday, November 20, 2024
Tuesday, November 19, 2024
Monday, November 18, 2024
Friday, November 15, 2024
Tuesday, November 12, 2024
Wednesday, October 30, 2024
- Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
- Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
- USDA Says H5N1 Bird Flu Detected In Swine For...
- USDA To Begin Bulk Milk Testing For Bird Flu ...
- BMO Capital Maintains Market Perform on Novar...
Tuesday, October 29, 2024
- FDA Grants Accelerated Approval To Novartis's...
- US CDC Reports 36 H5 Bird Flu Cases In U.S. S...
- Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
- Novartis shares are trading lower. The compan...
- Novartis 2024 Guidance Raised: Now Expects Ne...
- Novartis Q3 2024 Adj. EPS $2.06 Beats $1.96 E...